As required by the Fertility Clinic Success Rate and Certification Act of 1992, reproductive endocrinologists must report in-vitro fertilization (IVF) delivery rates to the Centers for Disease Control (CDC) and The Society of Assisted Reproductive Technology (www.SART.org), the primary organization of professionals dedicated to the practice of Assisted Reproductive Technologies in the United States.

2012_sart

RMANJ is pleased to share our most current success rates as reported to SART. As you can see, our rates are among the highest rates in the US for women under 35.  These outstanding delivery rates are the result of the experience and dedication of our healthcare providers, individualized IVF protocols, laboratory conditions and techniques like extended embryo culture, endometrial synchrony, trophectoderm biopsy, and breakthrough technologies like comprehensive chromosome screening (www.select-ccs.com).

Please click here to view RMANJ’s Clinic Summary Report.

 

Please note: A comparison of clinic success rates may not be meaningful because a patient’s medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic. Visit www.sart.org. to learn more.